Alpine Immune Sciences Inc (ALPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,762 | -38,898 | -25,625 | -7,527 | -50,333 |
| Depreciation Amortization | -103 | 1,086 | 895 | 480 | 1,526 |
| Income taxes - deferred | 46 | 113 | 107 | N/A | -214 |
| Accounts receivable | 24,602 | 24,618 | 23,683 | 24,868 | N/A |
| Accounts payable and accrued liabilities | 5,557 | 3,577 | 1,558 | -1,851 | 5,970 |
| Other Working Capital | 4,931 | 3,919 | 9,584 | 10,279 | 28,099 |
| Other Operating Activity | -21,025 | -21,383 | -20,822 | -20,800 | -296 |
| Operating Cash Flow | $-43,754 | $-26,968 | $-10,620 | $5,449 | $-15,248 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -112,936 | -5,153 | -30,998 | -37,777 | -52,362 |
| PPE Investments | -412 | -296 | -241 | -26 | -118 |
| Investing Cash Flow | $-113,348 | $-5,449 | $-31,239 | $-37,803 | $-52,480 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,800 | -3,600 | -2,400 | -1,200 | -2,400 |
| Common Stock Issued | 107,489 | 94,746 | 730 | 550 | 103,164 |
| Financing Cash Flow | $102,689 | $91,146 | $-1,670 | $-650 | $100,764 |
| Exchange Rate Effect | -118 | -11 | -18 | -14 | -88 |
| Beginning Cash Position | 68,161 | 68,161 | 68,161 | 68,161 | 35,213 |
| End Cash Position | 13,630 | 126,879 | 24,614 | 35,143 | 68,161 |
| Net Cash Flow | $-54,531 | $58,718 | $-43,547 | $-33,018 | $32,948 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,754 | -26,968 | -10,620 | 5,449 | -15,248 |
| Capital Expenditure | -412 | -296 | -241 | -26 | -118 |
| Free Cash Flow | -44,166 | -27,264 | -10,861 | 5,423 | -15,366 |